title: Safety of using anti-TNF-α blockers in cardiac failure associated with systemic inflammatory disease and the risk of Kounis syndrome.
authors: Department of Medical Sciences, Patras Highest Institute of Education and Technology, Patras, Greece. Electronic address: ngkounis@otenet.gr.
authors: Nicholas G
authors: NG
authors: Kounis
authors: George D
authors: GD
authors: Soufras
authors: George N
authors: GN
authors: Kounis
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D006801:Humans; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D012307:Risk Factors; D013577:Syndrome; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced* / Q000453:epidemiology / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha
keywords: Cardiac failure; Chimeric antibodies; Inflammatory disease; Kounis syndrome